Ovid Therapeutics (OVID) EPS (Basic) (2016 - 2026)
Ovid Therapeutics (OVID) posted EPS (Basic) of -$0.34 for Q1 2026, down 399.79% on a QoQ basis from $0.11 in Q4 2025, and up 32.62% year-over-year from -$0.26 in Q1 2025.
Ovid Therapeutics (OVID) EPS (Basic) (2016 - 2026) Analysis & Trends
Ovid Therapeutics' EPS (Basic) history runs 11 years deep, the most recent figure standing at -$0.34 for Q1 2026.
- Quarterly EPS (Basic) rose 32.62% year-over-year to -$0.34 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.48 (up 60.72% YoY) and the FY2025 annual result came in at -$0.2, up 96.37% from the prior year.
- EPS (Basic) was -$0.34 for Q1 2026 at Ovid Therapeutics, down from $0.11 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.12 in Q2 2024 and bottomed at -$1.97 in Q4 2024.
- A 5-year average of -$0.31 and a median of -$0.2 in 2024 frame the typical range for EPS (Basic).
- Peak annual rise in EPS (Basic) reached 168.3% in 2024, while the deepest fall reached 806.93% in 2024.
- Ovid Therapeutics' EPS (Basic) stood at -$0.16 in 2022, then slumped by 32.89% to -$0.22 in 2023, then sank by 806.93% to -$1.97 in 2024, then surged by 105.75% to $0.11 in 2025, then tumbled by 399.79% to -$0.34 in 2026.
- Business Quant data shows OVID's EPS (Basic) at -$0.34 in Q1 2026, $0.11 in Q4 2025, and -$0.61 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,933.35 Bn | 1,933.29 Bn | - | - |
| 3 | Akari Therapeutics | 1,063.56 Bn | 1,063.56 Bn | - | 0.00 |
| 4 | BeOne Medicines | 468.54 Bn | 463.75 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.20 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 63.57 Bn | 63.57 Bn | - | 0.00 |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 7.59 |
| 9 | Alnylam Pharmaceuticals | 37.75 Bn | 34.74 Bn | 959.66 Mn | 1.55 |
| 10 | Ovid Therapeutics | 121.66 Mn | -33.86 Mn | - | -0.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.34 |
| Dec 31, 2025 | 0.11 |
| Sep 30, 2025 | -0.61 |
| Jun 30, 2025 | -0.23 |
| Mar 31, 2025 | -0.50 |
| Dec 31, 2024 | -1.97 |
| Sep 30, 2024 | -0.20 |
| Jun 30, 2024 | 0.12 |
| Mar 31, 2024 | -0.17 |
| Dec 31, 2023 | -0.22 |
| Sep 30, 2023 | -0.16 |
| Jun 30, 2023 | -0.18 |
| Mar 31, 2023 | -0.19 |
| Dec 31, 2022 | -0.16 |
| Sep 30, 2022 | -0.17 |
| Jun 30, 2022 | -0.21 |
| Mar 31, 2022 | -0.23 |
| Dec 31, 2021 | -0.39 |
| Sep 30, 2021 | -0.17 |
| Jun 30, 2021 | -0.23 |